We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+24.07%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+647.83%
AUM
$15.1B
AUM Growth
+$3.18B
Cap. Flow
+$409M
Cap. Flow %
2.7%
Top 10 Hldgs %
24.45%
Holding
1,348
New
61
Increased
400
Reduced
581
Closed
83

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.4M
2
AAPL icon
Apple
AAPL
+$69.3M
3
NVDA icon
NVIDIA
NVDA
+$54.6M
4
AMZN icon
Amazon
AMZN
+$54.6M
5
ABBV icon
AbbVie
ABBV
+$53.8M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$80.3M
2
ADSK icon
Autodesk
ADSK
+$34.8M
3
ORCL icon
Oracle
ORCL
+$34.2M
4
JPM icon
JPMorgan Chase
JPM
+$34M
5
AZO icon
AutoZone
AZO
+$29.4M

Sector Composition

Rank Sector Weight
1 Technology 27.25%
2 Healthcare 18.79%
3 Financials 12.56%
4 Consumer Discretionary 11.24%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
76
Kimberly-Clark
KMB
$33B
$44.7M 0.3%
316,285
+128,328
+68% +$17.7M
BAX icon
77
Baxter International
BAX
$12.3B
$44.4M 0.29%
515,438
+101,996
+25% +$8.88M
AMAT icon
78
Applied Materials
AMAT
$337B
$44M 0.29%
727,896
+37,681
+5% +$2.03M
EQIX icon
79
Equinix
EQIX
$98.5B
$43.9M 0.29%
62,555
+7,149
+13% +$4.84M
REGN icon
80
Regeneron Pharmaceuticals
REGN
$81.7B
$42.5M 0.28%
68,205
+35,842
+111% +$20.3M
GILD icon
81
Gilead Sciences
GILD
$182B
$40.8M 0.27%
530,241
-77,665
-13% -$5.95M
LLY icon
82
Eli Lilly
LLY
$1.01T
$40.2M 0.27%
244,666
-158,519
-39% -$24.3M
ADP icon
83
Automatic Data Processing
ADP
$110B
$40.1M 0.26%
269,118
-8,332
-3% -$1.19M
ATVI
84
DELISTED
Activision Blizzard
ATVI
$40M 0.26%
527,050
+187,754
+55% +$13.1M
XYL icon
85
Xylem
XYL
$25.1B
$39.6M 0.26%
610,147
+13,194
+2% +$871K
AMD icon
86
Advanced Micro Devices
AMD
$805B
$39.2M 0.26%
745,200
-65,200
-8% -$3.46M
BIDU icon
87
Baidu
BIDU
$31.4B
$39.1M 0.26%
326,210
+206,153
+172% +$22.1M
NXPI icon
88
NXP Semiconductors
NXPI
$56.5B
$38.9M 0.26%
341,270
-7,386
-2% -$738K
MU icon
89
Micron Technology
MU
$1.04T
$38.2M 0.25%
741,995
+173,371
+30% +$8.17M
XOM icon
90
ExxonMobil
XOM
$679B
$37.7M 0.25%
843,347
-91,389
-10% -$4.1M
CVX icon
91
Chevron
CVX
$416B
$37.5M 0.25%
420,619
-20,861
-5% -$1.87M
ECL icon
92
Ecolab
ECL
$77.2B
$36.7M 0.24%
184,639
-125,045
-40% -$24.2M
INTU icon
93
Intuit
INTU
$90.6B
$36.7M 0.24%
124,019
-3,706
-3% -$1.02M
AWK icon
94
American Water Works
AWK
$27.6B
$36.7M 0.24%
285,298
-13,759
-5% -$1.71M
BKNG icon
95
Booking.com
BKNG
$132B
$36.7M 0.24%
575,450
+6,175
+1% +$376K
LIN icon
96
Linde
LIN
$214B
$36.3M 0.24%
171,143
-39,563
-19% -$7.64M
FISV
97
Fiserv Inc
FISV
$27.1B
$36.3M 0.24%
371,418
+254,882
+219% +$25.7M
BBY icon
98
Best Buy
BBY
$19.9B
$36M 0.24%
412,891
-3,038
-0.7% -$230K
BLK icon
99
Blackrock
BLK
$165B
$35.9M 0.24%
65,945
+20,363
+45% +$10.3M
GIS icon
100
General Mills
GIS
$19.5B
$35.6M 0.24%
577,643
+282,620
+96% +$17M

Similar funds

KBC Group's Q2 2020 Portfolio in Review

As of Q2 2020, KBC Group held 1,348 positions worth $15.1B, up 27% from $11.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

KBC Group's Q2 2020 filing shows 61 new, 400 increased, 581 reduced and 83 closed positions. Its largest new stake was Trade Desk: 211,220 shares worth $8.59M. The largest sale was Allergan plc, an estimated $80.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q2 2020 buy was Trade Desk: 211,220 shares worth $8.59M.
  • KBC Group added most to Microsoft in Q2 2020, an estimated $82.4M increase.
  • KBC Group's biggest Q2 2020 reduction was Autodesk, cutting an estimated $34.8M.
  • KBC Group fully exited Allergan plc in Q2 2020, selling an estimated $80.3M.
  • KBC Group's ten largest holdings make up 24% of its $15.1B portfolio in Q2 2020.
  • KBC Group opened 61 new positions and closed 83 in Q2 2020.
  • KBC Group's portfolio value rose 27% quarter-over-quarter to $15.1B.

Based on KBC Group's 13F filing for Q2 2020, filed 10 Aug 2020.